Abstract:Obesity is accompanied by an increase in both adipocyte number and size. The increase in adipocyte number is the result of recruitment to the adipocyte lineage of pluripotent stem cells present in the vascular stroma of adipose tissue. These pluripotent cells have the potential to undergo commitment and then differentiate into adipocytes, as well as myocytes, osteocytes, and chondrocytes. In this article, we show that both bone morphogenetic protein (BMP)2 and BMP4 can induce commitment of C3H10T1/2 pluripotent stem cells into adipocytes. After treatment of C3H10T1/2 stem cells with these BMPs during proliferation followed by exposure to differentiation inducers at growth arrest, nearly all cells enter the adipose development pathway, express specific adipocyte markers, and acquire the adipocyte phenotype. Overexpression of constitutively active BMP receptor (CA)-BMPr1A or CA-BMPr1B induces commitment in the absence of BMP2/4, whereas overexpression of a dominant-negative receptor dominant-negative-BMPr1A suppresses commitment induced by BMP. Also, knockdown of the expression of Smad4 (coregulator in the BMP/Smad signaling pathway) with RNAi disrupts commitment by the BMPs. However, knockdown of expression of p38 MAPK (an intermediary in the BMP/MAPK signaling pathway) with RNAi had little effect on BMP-induced commitment. Together, these findings indicate that the BMP/Smad signaling pathway has a dominant role in adipocyte lineage determination. Proteomic analysis identified lysyl oxidase (LOX), a bona fide downstream target gene of the BMP signaling pathway. Expression of LOX is induced by BMP2/4 during adipocyte lineage commitment, and knockdown of its expression disrupts the commitment process.

Fine-tuning BMP 7 signalling in adipogenesis by UBE 2 O / E 2230 K-mediated monoubiquitination of SMAD 6

Fine-tuning BMP7 Signalling in Adipogenesis by UBE2O/E2-230K-mediated Monoubiquitination of SMAD6

Supplementary Figure S5 from AMBRA1 Promotes TGFβ Signaling Via Nonproteolytic Polyubiquitylation of Smad4

N 6 -Methyladenosine Modification-Mediated Mrna Metabolism is Essential for Human Pancreatic Lineage Specification and Islet Organogenesis

BMP Signaling Pathway is Required for Commitment of C3H10T1/2 Pluripotent Stem Cells to the Adipocyte Lineage.

Comparative Transcriptomic and Epigenomic Analyses Reveal New Regulators of Murine Brown Adipogenesis

UBE2C orchestrates bone formation through stabilization of SMAD1/5

The Regulation of TGF-β/SMAD Signaling by Protein Deubiquitination

Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination

The Deubiquitinating Enzyme UCH37 Interacts with Smads and Regulates TGF-β Signalling

Dynamic Molecular Architecture and Substrate Recruitment of Cullin3–ring E3 Ligase CRL3KBTBD2

C-terminal Domain (CTD) Small Phosphatase-like 2 Modulates the Canonical Bone Morphogenetic Protein (BMP) Signaling and Mesenchymal Differentiation Via Smad Dephosphorylation*

SUMOylation of Smad2 mediates TGF-β-regulated endothelial-mesenchymal transition

BMP8B Activates Both SMAD2/3 and NF-κB Signals to Inhibit the Differentiation of 3T3-L1 Preadipocytes into Mature Adipocytes

The Role of Ccaat/Enhancer Binding Protein (C/ebp)-Alpha in Osteogenesis of C3h10t1/2 Cells Induced by Bmp-2

Visualization and Quantification of Browning Using a Ucp1-2A-Luciferase Knock-in Mouse Model.

Reversible Ubiquitination Regulates the Smad/TGF-β Signalling Pathway

SCF FBXL15 regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1

Supplementary Figure S6 from AMBRA1 Promotes TGFβ Signaling Via Nonproteolytic Polyubiquitylation of Smad4

SIRT6 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells Through BMP Signaling.

Differential Ubiquitination of Smad1 Mediated by Chip: Implications in the Regulation of the Bone Morphogenetic Protein Signaling Pathway